EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy

Anna Maria Costa iD, Mohammad Gol, Chiara Lucchi iD, Giuseppe Biagini iD

Epilepsia · 2023

DOI: 10.1111/epi.17561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Anna Maria Costa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Neurosteroids, Status Epilepticus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Epileptogenesis after status epilepticus (SE) has a faster onset in rats treated to reduce brain levels of the anticonvulsant neurosteroid allopregnanolone with the 5α‐reductase inhibitor finasteride; however, it still has to be evaluated whether treatments aimed at increasing allopregnanolone levels could result in the opposite effect of delaying epileptogenesis. This possibility could be tested using the peripherally active inhibitor of 3β‐hydroxysteroid dehydrogenase/Δ 5‐4 isomerase trilostane, which has been shown repeatedly to increase allopregnanolone levels in the brain.

Methods

Trilostane (50 mg/kg) was administered subcutaneously once daily for up to six consecutive days, starting 10 min after intraperitoneal administration of kainic acid (15 mg/kg). Seizures were evaluated by video‐electrocorticographic recordings for 70 days maximum, and endogenous neurosteroid levels were assessed by liquid chromatography–electrospray tandem mass spectrometry. Immunohistochemical staining was performed to evaluate the presence of brain lesions.

Results

Trilostane did not alter the latency of kainic acid‐induced SE onset or its overall duration. When compared to the vehicle‐treated group, rats receiving six daily trilostane injections presented a remarkable delay of the first spontaneous electrocorticographic seizure and subsequent tonic–clonic spontaneous recurrent seizures (SRSs). Conversely, rats treated with only the first trilostane injection during SE did not differ from vehicle‐treated rats in developing the SRSs. Notably, trilostane did not modify neuronal cell densities or the overall damage in the hippocampus. In comparison to the vehicle group, repeated administration of trilostane significantly decreased the activated microglia morphology in the subiculum. As expected, allopregnanolone and other neurosteroid levels were remarkably increased in the hippocampus and neocortex of rats treated for 6 days with trilostane, but pregnanolone was barely detectable. Neurosteroids returned to basal levels after a week of trilostane washout. Significance Overall, these results suggest that trilostane led to a remarkable increase in allopregnanolone brain levels, which was associated with protracted effects on epileptogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeNeurosteroidsStatus EpilepticusRatsAnimalsKainic AcidPregnanoloneRats, Sprague-DawleySeizuresDihydrotestosterone

Stichwörter der Autor:innen

epileptogenesiskainic acidneurosteroidsstatus epilepticustemporal lobe epilepsytrilostane

Substanzen

Kainic AcidPregnanoloneNeurosteroidstrilostaneDihydrotestosterone

Autor:innen und Institutionen

  • Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • PhD School of Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy.

ORCID-Profile: Anna Maria Costa, Chiara Lucchi, Giuseppe Biagini

Zitieren

APA

Costa, A. M., Gol, M., Lucchi, C., & Biagini, G. (2023). Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy. Epilepsia. https://doi.org/10.1111/epi.17561

Vancouver

Costa AM, Gol M, Lucchi C, Biagini G. Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy. Epilepsia. 2023. doi:10.1111/epi.17561

BibTeX
@article{Costa2023,
  author = {Costa, Anna Maria and Gol, Mohammad and Lucchi, Chiara and Biagini, Giuseppe},
  title = {Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17561}
}
Kostenlos starten →